688238 logo

Obio Technology (Shanghai) XSSC:688238 Stock Report

Last Price

CN¥5.58

Market Cap

CN¥3.6b

7D

-1.6%

1Y

-6.4%

Updated

12 May, 2025

Data

Company Financials +

Obio Technology (Shanghai) Corp., Ltd.

XSSC:688238 Stock Report

Market Cap: CN¥3.6b

688238 Stock Overview

A biotechnology company, focuses on the development of gene therapy vectors in China. More details

688238 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 16.6% below our estimate of its fair value

Revenue is forecast to grow 12.81% per year

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months compared to the CN market


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Obio Technology (Shanghai) Corp., Ltd. Competitors

Shanghai Medicilon

SHSE:688202

CN¥4.0b

Shanghai Innostar Biotechnology

SHSE:688710

CN¥4.4b

PharmaResources (Shanghai)

SZSE:301230

CN¥4.1b

R&G PharmaStudies

SZSE:301333

CN¥4.2b

Price History & Performance

Summary of share price highs, lows and changes for Obio Technology (Shanghai)
Historical stock prices
Current Share PriceCN¥5.58
52 Week HighCN¥6.88
52 Week LowCN¥3.86
Beta0.55
1 Month Change2.76%
3 Month Change6.69%
1 Year Change-6.38%
3 Year Changen/a
5 Year Changen/a
Change since IPO-57.08%

Recent News & Updates

Recent updates

Shareholder Returns

688238CN Life SciencesCN Market
7D-1.6%-0.2%2.3%
1Y-6.4%11.6%6.7%

Return vs Industry: 688238 underperformed the CN Life Sciences industry which returned 11.6% over the past year.

Return vs Market: 688238 underperformed the CN Market which returned 6.7% over the past year.

Price Volatility

Is 688238's price volatile compared to industry and market?
688238 volatility
688238 Average Weekly Movement10.5%
Life Sciences Industry Average Movement8.1%
Market Average Movement7.1%
10% most volatile stocks in CN Market10.5%
10% least volatile stocks in CN Market4.4%

Stable Share Price: 688238's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 688238's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
2013722Guodong Jiawww.obiosh.com

Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China. The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research. It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.

Obio Technology (Shanghai) Corp., Ltd. Fundamentals Summary

How do Obio Technology (Shanghai)'s earnings and revenue compare to its market cap?
688238 fundamental statistics
Market capCN¥3.62b
Earnings (TTM)-CN¥339.12m
Revenue (TTM)CN¥241.42m

15.0x

P/S Ratio

-10.7x

P/E Ratio

Is 688238 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688238 income statement (TTM)
RevenueCN¥241.42m
Cost of RevenueCN¥341.97m
Gross Profit-CN¥100.54m
Other ExpensesCN¥238.58m
Earnings-CN¥339.12m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.52
Gross Margin-41.65%
Net Profit Margin-140.47%
Debt/Equity Ratio19.6%

How did 688238 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 15:00
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Obio Technology (Shanghai) Corp., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hao WuChasing Securities
Wanhua WuChina International Capital Corporation Limited
Xiao Wei LinEverbright Securities Co. Ltd.